"VolparaEnterprise software is the only solution currently available that provides a comprehensive assessment of image quality on every screening mammogram, including such factors as positioning and compression, which can significantly impact the quality of the image. In fact, the FDA attributes poor positioning to be the cause of most clinical image deficiencies and most failures of accreditation," said Ralph Highnam, PhD, Volpara Chief Scientist and CEO. "The wide array of quality control features and performance data we provide enhance quality and productivity, and help facilities more easily comply with the new EQUIP requirements."
VolparaEnterprise software, which delivers key performance indicators (KPIs) for hundreds of performance and quality metrics, including positioning, compression and equipment utilization, is designed to help sites prepare for the EQUIP inspection questions:
- VolparaEnterprise monitors every screening mammogram for image quality issues related to positioning and compression.
- VolparaEnterprise data's easy sorting by technologist helps isolate cases for EQUIP review.
- VolparaEnterprise can help rapidly locate poor quality images for review during Image Review Quality Meetings (as well as good-quality images for review in preparation for machine accreditation).
Designed to support large or small enterprises, VolparaEnterprise software enables breast imaging providers to provide objective evidence to demonstrate compliance and quality of care. Users can perform rapid quality control checks to optimize the productivity and efficiency of imaging resources, to help reduce costs through the reduction of retakes, and to increase staff effectiveness. The Microsoft Azure–based solution provides real-time quality assurance and performance monitoring through dynamic, interactive dashboards.
Further information from the FDA regarding the EQUIP initiative can be found here: EQUIP: Enhancing Quality Using the Inspection Program
About Volpara Solutions
Founded with the goal of helping radiologists give women the most accurate information possible regarding their breast health, Volpara Solutions is the wholly owned sales and marketing arm of Volpara Health Technologies Limited of New Zealand (formerly Matakina Technology). Available in most markets where breast cancer screening is commonplace, VolparaDensity provides an objective volumetric measure of breast density from both digital mammography and tomosynthesis data. VolparaDensity is part of a suite of quantitative breast imaging tools built on the Volpara Solutions algorithm that allows for personalized measurements of density, patient-specific x-ray dose, breast compression, breast positioning and other factors designed to provide critical insight for breast imaging workflow. For more information, visit www.volparasolutions.com.
Logo - http://photos.prnewswire.com/prnh/20160713/389465LOGO
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/volparaenterprise-software-will-help-breast-imaging-providers-comply-with-fdas-new-enhancing-quality-using-the-inspection-program-equip-300358006.html
SOURCE Volpara Solutions